drugset / Trial / NCT00512278
Infliximab Treatment Along With Pegylated Interferon and Ribavirin in the Treatment of Hepatitis C
RandomizedParallel-groupTriple-blindTreatment
Summary
The aim of the study is to investigate in subjects receiving their first course of peg-interferon α-2b plus ribavirin therapy for chronic HCV infection
Timeline
- Start
- 2007-07
- Primary completion
- 2012-05
- Completion
- 2012-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Infliximab | Monoclonal antibody | — | Other |